Clinical evaluation of isonicotinic acid hydrazide as an adjuvant in the treatment of lepromatous leprosy; with a note on the detrimental effect of erythema nodosum leprosum reactions.
D000276:Adjuvants, Immunologic; D000277:Adjuvants, Pharmaceutic; D004893:Erythema Nodosum; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D007918:Leprosy / Q000628:therapy*; D015440:Leprosy, Lepromatous; D017192:Skin Diseases, Bacterial
D000276:Adjuvants, Immunologic; D000277:Adjuvants, Pharmaceutic; D007538:Isoniazid
ISONIAZID/therapeutic use; LEPROSY/therapy